(PRWEB) April 26, 2013
A recent report published by the Institute for Safe Medication Practices said users of Type 2 diabetes drugs such as Byetta were 25 times more likely to develop pancreatic cancer than those who used other diabetes drugs. The Rottenstein Law Group, which is accepting clients in Byetta lawsuits, maintains a Byetta Legal Information Center on its website designed to provide more information on Byetta side effects and lawsuits.
The ISMP used data from a year’s worth of U.S. Food and Drug Administration’s Adverse Events Reports.* Over the course of that year, there were 105 reported cases of pancreatic cancer, compared to two cases for a different class of diabetes drugs, according to the report.** This study comes on the heels of a UCLA study that according to Bloomberg*** indicated that Byetta users showed increased evidence of pre-cancerous cellular changes by as much as 40 percent.
“Given the evidence, it seems appropriate that Type 2 diabetes drugs like Byetta are the subject of increased regulatory scrutiny,” said Rochelle Rottenstein, principal of the Rottenstein Law Group. “If lawsuits do increase throughout the country, this is more evidence that could potentially be used in court to help plaintiffs’ attorneys argue their cases.”
The Rottenstein Law Group encourages those who believe Byetta injured them to visit its website and contact the firm today.
About THE ROTTENSTEIN LAW GROUP
The Rottenstein Law Group is a New York-based firm that represents clients nationwide in mass tort actions. The firm was founded by Rochelle Rottenstein, who has more than two decades of experience as a lawyer, to represent clients hurt by defective medications and medical devices. (Attorney advertising. Prior results do not guarantee a similar outcome.)
The Rottenstein Law Group, LLP
Rochelle Rottenstein, Esq.
321 W. 44th Street
New York NY 10036
(212) 933-9500 (office phone)
(212) 933-9980 (facsimile)
rochelle (at) rotlaw (dot) com